Acadia Pharmaceuticals
ACAD
ACAD
339 hedge funds and large institutions have $3.67B invested in Acadia Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 113 increasing their positions, 127 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
11% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 127
17% less capital invested
Capital invested by funds: $4.44B → $3.67B (-$775M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
339
Holding in Top 10
3
Calls
$12.9M
Puts
$8.35M
Top Buyers
| 1 | +$31.8M | |
| 2 | +$25.7M | |
| 3 | +$19.2M | |
| 4 |
BlackRock
New York
|
+$19M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$16.2M |
Top Sellers
| 1 | -$37.9M | |
| 2 | -$19.1M | |
| 3 | -$18.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17.8M |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$11.3M |
